Then again, we did not secure these vaccines until August, with an announcement. To my point, that wasted three months, which is the unfortunate part.
In January, Pfizer announced with its partner BioNTech that it was developing a booster shot to protect against the COVID variants. Just last week at the health committee, Dr. Roman Szumski mentioned that the current contracts that are in place do not reference the need for boosters and that those would be new conversations we would enter into with the suppliers.
Given this, is it important that we begin to engage now with firms, particularly these Canadian firms here today, including universities, to begin that process?